Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Repsher

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Allergy and Clinical Immunology|May 1, 1987
Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthmaR A Nathan, I L Bernstein, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1987
Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patientsJ L Pinnas, I L Bernstein, E E Bronsky, et al.
The American Journal of Medicine|January 29, 1996
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary diseaseD C Levin, K S Little, K R Laughlin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Allergy and Clinical Immunology|May 1, 1987
Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthmaR A Nathan, I L Bernstein, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1987
Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patientsJ L Pinnas, I L Bernstein, E E Bronsky, et al.
The American Journal of Medicine|January 29, 1996
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary diseaseD C Levin, K S Little, K R Laughlin, et al.
Pageof 2